[Pharmacokinetics of stearyl-ara-CMP (YNK-01) in patients with hematologic neoplasms].
Ueda
T
T
First Dept. of Medicine, Fukui Medical School.
Kamiya
K
K
Tanaka
T
T
Tsutani
H
H
Wano
Y
Y
Sugiyama
M
M
Nakamura
T
T
D000208:Acute Disease; D000970:Antineoplastic Agents / Q000493:pharmacokinetics*; D001088:Arabinonucleotides / Q000493:pharmacokinetics*; D003568:Cytidine Monophosphate / Q000031:analogs & derivatives / Q000493:pharmacokinetics*; D003597:Cytosine Nucleotides / Q000493:pharmacokinetics*; D004341:Drug Evaluation; D006801:Humans; D007938:Leukemia / Q000378:metabolism*; D009190:Myelodysplastic Syndromes / Q000378:metabolism*
D000970:Antineoplastic Agents; D001088:Arabinonucleotides; D003597:Cytosine Nucleotides; C061162:1-arabinofuranosylcytosine-5'-stearylphosphate; D003568:Cytidine Monophosphate